Obesity Management and Redux

Obesity Management and Redux book cover

Obesity Management and Redux

Author(s): Stylianos Nicolaidis (Author)

  • Publisher: Academic Press
  • Publication Date: December 19, 1996
  • Edition: 1st
  • Language: English
  • Print length: 144 pages
  • ISBN-10: 0125181701
  • ISBN-13: 9780125181709

Book Description

Redux™ is a revolutionary new anti-obesity drug that has just been approved (July 1996) by the FDA. It is the first weight management drug treatment to be launched in the United States in 20 years and is not addictive, unlike earlier drugs used for this purpose. Obesity Management and Redux™ includes a brief introduction which leads up to its discovery and includes an overview of new trends in obesity management. The book lists the pharmacological profile of the drug, given by experts involved in monitoring the effects of the drug on the brain neurotransmitters, as well as detailing the results (including safety data) of the various clinical trials.

  • Covers all aspects of a revolutionary new drug
  • Lists pharmacological profile of the drug
  • Includes safety data
  • Projects future trends in weight management

Editorial Reviews

Review

New Study on Revolutionary Anti-Obesity Drug!

From the Back Cover

Obesity is a chronic disease that is increasing in prevalence. It contributes greatly to overall morbidity and mortality, but has proved particularly difficult to control.However, Redux (dexfluramine), a recently marketed drug in the United States, enjoys a favourable benefit risk ratio, and has shown that it is able to maintain weight loss without the side effects of amphetamine drugs.This book is an up to date survey of all aspects of obesity authored by internationally renowned experts in the field and focusing on Reduc as a long-term adjunct to weight control. It will be of great interest to all those involved with eating behavior, and those who want a conprehensive overview of Redux.

View on Amazon

未经允许不得转载:Wow! eBook » Obesity Management and Redux